Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C

BACKGROUND: Our recent study showed that tetrathiomolybdate (TM), a drug to treat copper overload disorders, can sensitize drug-resistant endometrial cancer cells to reactive oxygen species (ROS)-generating anticancer drug doxorubicin. To expand these findings in the present study we explore TM effi...

Full description

Saved in:
Bibliographic Details
Main Authors: Kim, Kyu Kwang, Lange, Thilo S, Singh, Rakesh K, Brard, Laurent, Moore, Richard G
Format: Artigo
Language:Inglês
Published: BioMed Central 2012
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3353246/
https://ncbi.nlm.nih.gov/pubmed/22502731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-147
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items